HIV drugmakers ViiV, Gilead top pharma reputation survey by Beth Snyder Bulik Thursday, April 18, 2019 Pharma’s reputation is holding steady with patient groups with an annual study finding 41% giving pharma good marks, similar to 43% the year before.
U.S. patient groups might just be warming up to pharma by Beth Snyder Bulik Monday, May 14, 2018 U.S. patient groups ranked pharma higher in patient-centricity, integrity and partnerships, a survey found. One U.S. company even won pricing kudos.
Pharma's U.S. reputation is bad—and Trump may be to blame by Beth Snyder Bulik Wednesday, July 19, 2017 The pharma industry’s reputation among patient groups in the U.S. has sunk to a recent low, and some are pointing to the country's leader as the reason.
Pharma's rep with patient groups drops again by Beth Snyder Bulik Tuesday, March 21, 2017 After an upswing in pharma's global reputation in 2015, its standing among patient groups has swung the other way—again.
